Phenotypic screening in drug discovery continues to be revived With all the expectation of offering promising lead compounds and drug targets and improving the achievements level of drug approval. Nonetheless, target identification continues to be A significant bottleneck in phenotype-based drug discovery. We determined the lead compounds K542 and K405 https://ddatp90011.blog4youth.com/27042437/detailed-notes-on-sr-4835